Your browser doesn't support javascript.
loading
Studies on the partial characterization of extracted glycosaminoglycans from fish waste and its potentiality in modulating obesity through in-vitro and in-vivo.
V, Geetha; Das, Moumita; Zarei, Mehrdad; Vp, Mayookha; Harohally, Nanishankar V; G, Suresh Kumar.
Afiliação
  • V G; Department of Biochemistry, CSIR-Central Food Technological Research Institute, 570 020, Mysore, India.
  • Das M; Department of Biochemistry, CSIR-Central Food Technological Research Institute, 570 020, Mysore, India.
  • Zarei M; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Vp M; Department of Biochemistry, CSIR-Central Food Technological Research Institute, 570 020, Mysore, India.
  • Harohally NV; Department of Biochemistry, CSIR-Central Food Technological Research Institute, 570 020, Mysore, India.
  • G SK; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Glycoconj J ; 39(4): 525-542, 2022 08.
Article em En | MEDLINE | ID: mdl-35913650
ABSTRACT
Glycosaminoglycans (GAGs) are bioactive polysaccharides or glycoconjugates found in the fish waste having significant health impacts. In the present study it has been attempted to extract GAGs from mackerel fish waste through chemical and enzymatic methods. Further, the extracted GAGs (e-GAGs) were analyzed for their composition (uronic acid, total sugar & sulfate), chemical characterization was carried out through techniques of scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) & Proton NMR. Further, probable major GAGs present was identified by enzymatic digestion. The biological potential of the extracted glycoconjugate was assessed further through in-vitro and in-vivo studies. In-vitro biological activity showed good lipase inhibition (IC50, 2.6 mg/mL) and bile acid binding properties (dose-dependent). Lipid accumulation lowered in the e-GAGs differentiated 3T3L1 preadipocyte cells have also been observed. The high fat fed animal (in-vivo) study showed ameliorative effect via reducing blood sugar∼1.28↓, lipid profile↓, plasma insulin∼3.5↓, improved glucose tolerance, and homeostatic model assessment for insulin resistance (HOMA-IR, ∼3.0↓). Furthermore, elimination of bile acid (BA) due to GAG-BA binding properties resultant in removal of elevated fecal triglyceride and cholesterol suggesting its lipid lowering activity. Regulation of various proteins linked to carbohydrate and lipid metabolism including fatty acid synthase (FAS), low density lipoproteins receptor (LDL-R), 7α-hydroxylase, glucose transporter-4 (GLUT4) and Peroxisome proliferator- activated receptor gamma (PPAR-γ) were significant (p < 0.05) with e-GAGs treatment when compared to HFD group. Thus, the e-GAGs showed potential hypolipidemic activity through elimination of bile acid binding property together with regulating the specific protein related to obesity and its associated complications.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicosaminoglicanos / Obesidade Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicosaminoglicanos / Obesidade Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article